Ann: Bod to supply medicinal cannabis for a landmark PTSD trial, page-12

Realistically BOD has not even had their product dispensed to 50 patients in history in spite of even being available on he market for > 1 year. Their COGs to bring in from overseas allows them to generate minuscule profit per sale. (Likely to be under $20/ bottle). The product is generic CBD which is purchased from a wholesale white labelled manufacturer. Anyone can replicate and replace this product. The product is not specific to PTSD and has no evidence that it is better than placebo for PTSD. Let's not kid ourselves.